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We have demonstrated that rpsL, encoding the S12 protein of the small ribosomal subunit, can be used as
a counterselectable marker in Borrelia burgdorferi, the causative agent of Lyme disease. Mutations in rpsL
confer streptomycin resistance. Streptomycin susceptibility is dominant in an rpsL merodiploid, and strepto-
mycin selects for the loss of wild-type rpsL carried in trans. This is the first description of a counterselectable
marker in B. burgdorferi.
The approach for genetically manipulating Borrelia burgdorferi,
a spirochete that causes Lyme borreliosis (2, 6, 23), has slowly
matured over the past 15 years (17, 18). A number of selectable
markers conferring antibiotic resistance have been developed and
used to disrupt genes and maintain plasmids, including gyrB
(Cour) (21), aphI (Kanr) (5), ermC (Ermr) (22), aadA (Spt/Strr)
(9), and aacC1 (Genr) (8), which have enabled effective, if not
efficient, molecular genetic tools. However, to date, no counters-
electable marker has been available to select for the loss of a
particular DNA sequence (16). We now demonstrate that sus-
ceptibility to streptomycin is dominant in a merodiploid carrying
a wild-type rpsL allele and a streptomycin-resistant rpsL allele and
that rpsL can function as a counterselectable marker in B. burg-
dorferi. This now provides a genetic tool, previously unavailable,
for studying the biology of B. burgdorferi and the pathogenesis of
Lyme disease.
In Escherichia coli, the rpsL gene encodes the S12 ribosomal
protein of the 30S subunit. Streptomycin exerts its antimicro-
bial activity by binding to 16S rRNA, near the binding interface
of S12, to inhibit protein synthesis by increasing translational
errors through the recruitment of incorrect tRNAs (11, 12).
Mutations in rpsL confer resistance in numerous bacteria, in-
cluding E. coli (4, 10, 14) and the spirochete Leptospira biflexa
(15). Streptomycin inhibits the growth of streptomycin-resis-
tant rpsL mutants when wild-type (streptomycin-sensitive) rpsL
is expressed in trans, indicating that the antibiotic susceptibility
phenotype is dominant (13). Furthermore, growing merodip-
loid rpsL strains in the presence of streptomycin can select for
the loss of wild-type rpsL, demonstrating the utility of this gene
as a counterselectable marker (16).
We recently isolated B. burgdorferi mutants that were 10-fold
more resistant to streptomycin than the parental strain, B31-A
(7). One isolate contained a mutation in rpsL encoding the
single amino acid substitution K88E in S12, the same residue
that was found to be mutated in streptomycin-resistant L.
biflexa (15) and E. coli (10). We constructed an rpsL merodip-
loid strain to test the feasibility of streptomycin susceptibility as
a counterselectable marker in B. burgdorferi.
Construction of a counterselectable marker. rpsL was ampli-
fied from B. burgdorferi strain B31-A3 genomic DNA by PCR
using the primers rpsLU133FSgrAI (5-CGCCGGTGACTGG
AACTGGTATGGGTC-3) and rpsL375RSgrAI (5-CACCG
GCGTTAAGCTTTAGGCTTTTTTGTTC-3). The PCR prod-
uct was cloned into pCR2.1-TOPO (Invitrogen) to yield pTArpsL
and confirmed by direct sequencing. pTArpsL was digested with
XhoI and SacI and ligated into the Borrelia shuttle vector pBSV2
(24), which had been digested with SalI and SacI, to yield
pBSrpsL (Fig. 1A). Low-passage B31-A was transformed with
pBSrpsL, and the streptomycin-resistant strain DCSmR4 (7) was
transformed with either pBSrpsL or the empty vector pBSV2,
essentially as described previously (19). Cultures of transformants
were diluted with Barbour-Stoenner-Kelly (BSK) II medium (1)
containing kanamycin (200 g/ml) in 96-well plates (25) to select
for those containing pBSV2 or pBSrpsL harboring the kanamycin
resistance gene aphI. Positive wells were screened for the
presence of the plasmids by PCR using the primers PflgB5
MfeI (5-CAATTGTACCCGAGCTTCAAGGAA-3) and
KanR 488R (5-TCACTCGCATCAACCAAACC-3) to de-
tect aphI. Clones were chosen from 96-well plates that had
fewer than 10 positive wells because the probability that a
well was inoculated with a single cell is greater than 0.94
(J. M. Graham and D. S. Samuels, unpublished data).
Phenotype of rpsL merodiploid. We first tested the hypoth-
esis that streptomycin susceptibility is dominant in an rpsL
merodiploid. Each strain was initially grown in liquid BSK II
medium containing only kanamycin to maintain pBSV2 or
pBSrpsL. Borrelia spirochetes were then counted using a
Petroff-Hausser counting chamber, and 1,000 spirochetes were
plated in semisolid BSK medium (19) containing (i) no anti-
biotics, (ii) kanamycin (200 g/ml), (iii) streptomycin (50 g/
ml), or (iv) kanamycin plus streptomycin. Plates were incu-
bated at 37°C and 5% CO2 for 2 weeks before enumeration.
The merodiploid strain DCSmR/pBSrpsL did not form colo-
nies in the presence of both kanamycin and streptomycin,
suggesting that streptomycin susceptibility is dominant (Table
1). A few DCSmR/pBSrpsL colonies formed in the presence of
streptomycin alone (Table 1). Similar results were confirmed
using a second DCSmR/pBSrpsL clone (data not shown). The
frequency of loss of pBSrpsL (0.04%) is much lower than we
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have observed with another counterselectable marker system
using fluoroquinolones and parC (3%) (18); the higher rate
of plasmid loss in the parC mutants may be due to a partition-
ing defect. However, the pBSV2 backbone vector is stable, with
100% retention after 90 generations without selection (24).
Counterselection with rpsL. Streptomycin should select for
streptomycin-resistant Borrelia spirochetes that have lost
pBSrpsL, which confers susceptibility, and that carry only the
genomic rpsL allele conferring streptomycin resistance (Fig.
1B). To confirm that kanamycin-resistant colonies retained
pBSrpsL and streptomycin-resistant colonies lost pBSrpsL,
DNA from individual colonies was analyzed by xenodiagnosis
and PCR. In each experiment five randomly selected colonies
from each plate were grown in liquid BSK II medium (con-
taining either kanamycin or streptomycin) and total genomic
DNA was isolated as previously described (20). For xenodiag-
nosis, chemically competent E. coli DH5 cells were trans-
formed with genomic DNA and plated on lysogeny broth (3)
plates containing kanamycin to select for transformants car-
rying pBSrpsL. DNA from kanamycin-resistant DCSmR/pBSrpsL
Borrelia yielded kanamycin-resistant E. coli colonies in all cases
(15/15), suggesting that pBSrpsL was present, while no colo-
nies were observed using DNA from streptomycin-resistant
DCSmR/pBSrpsL (0/15).
To confirm these results, total genomic DNA was used to
screen for the presence of pBSrpsL by PCR analysis using
primers PflgB5MfeI and KanR 488R. All 15 kanamycin-
resistant DCSmR/pBSrpsL clones were positive for pBSrpsL by
PCR, while all 15 streptomycin-resistant DCSmR/pBSrpsL
clones were negative. Although the absence of a genetic ele-
ment cannot be proven, these data, taken together, suggest
that streptomycin can be used to select for the loss of the
wild-type rpsL allele, conferring streptomycin susceptibility, in
a merodiploid (DCSmR/pBSrpsL). Thus, rpsL can function as
a counterselectable marker and should be a useful molecular
tool for genetic experiments that require the loss of a DNA
sequence. We are currently isolating rpsL mutations in low-
passage infectious strains, and we are attempting to apply the
counterselectable marker system for use in the animal model
of Lyme borreliosis.
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